Pulse Biosciences, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Pulse Biosciences, Inc. (PLSE) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $132.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-01
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $132.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $263.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $132.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $263.00K 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |